Efficacy and Patient Satisfaction of Dipeptidyl Peptidase-4 Inhibitor After Switching From Once-Daily DPP-4 Inhibitor to Once-Weekly Regimen

BACKGROUND: We administered once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor (W) (used omarigliptin as W in this study) to patients with type 2 diabetes taking once-daily DPP-4 inhibitor (D), and investigated efficacy, safety and patient satisfaction before and after switching to W. METHODS: W w...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Katsunori, Hasegawa, Kazuki, Watanabe, Mio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031251/
https://www.ncbi.nlm.nih.gov/pubmed/29977422
http://dx.doi.org/10.14740/jocmr3456w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031251/
https://www.ncbi.nlm.nih.gov/pubmed/29977422
http://dx.doi.org/10.14740/jocmr3456w

Ejemplares similares